Abstract
The emergence of next-generation sequencing (NGS) technologies has facilitated the accumulation of large genomic datasets for most types of cancer. The analysis of these data has confirmed the early predictions of extensive sequence and structural diversity of cancer genomes, fueling the development of new computational approaches to decipher inter- and intratumoral somatic variation within and among cancer patients. Overall, these techniques have led to a better understanding of the disease as well as to relevant improvements in the diagnosis and therapy of cancer. In this chapter, we review current approaches for the analysis of somatic mutations in cancer genomes using NGS.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call